Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 150,000 | $3,114,000 | 0.02% | ||
| 2. | Navellier & Associates Louis Navellier | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.00 | 9,463 | $283,890.00 | 299,368 | 2026-04-20 | Filing | |
| $29.96 | 19,645 | $588,615.28 | 262,954 | 2026-04-20 | Filing | |
| $27.83 | 18,005 | $501,158.37 | 270,046 | 2026-04-17 | Filing | |
| $25.90 | 36,922 | $956,146.88 | 281,867 | 2026-04-16 | Filing | |
| $19.98 | 3,975 | $79,408.58 | 318,789 | 2026-04-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,183,813 | $211,415,958 | 0.01% | |
| 2. | 9,339,711 | $193,892,400 | 0% | |
| 3. | 4,151,638 | $86,188,005 | 0.01% | |
| 4. | Imc-chicago, LlcCALL | 2,742,500 | $56,934,300 | 0.02% |
| 5. | 2,338,600 | $48,549,336 | 0.26% |
News See All
10 Stocks With Monster Returns
Notably, investors poured funds into industries with promising growth prospects, namely semiconductor and quantum computing, while some favored pharmaceutical players thanks to progress on their pipeline...
Here’s How Cedar Grove Capital Management Benefitted from Its Short Position in Hims & Hers Health (HIMS)
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here.
10 Stocks With Unexpected Gains
Ten stocks kicked off the trading week with significant gains, mirroring Wall Street's broader optimism, as investors cheered strong US jobs data while waiting on the sidelines for developments on the...
7 Best Stocks to Buy for Short Term
In a continuously evolving market, investing has become a game of timing and informed decision-making.
10 Stock Market Casualties You Can't Ignore Today: UEC, Super Micro and More
Kratos Defense extended its losing streak to a third consecutive session on Friday, shedding 8.79 percent to close at $84.62 apiece and mirroring the broader market downturn, after President Donald Trump...
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on TopSecretStocks’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers (HIMS) Soars 57.4% on New Deal
Hims & Hers saw its share prices jump by 57.4 percent week-on-week, with the rally primarily driven by its renewed partnership with Novo Nordisk, as well as analysts’ upgraded price targets for its ...
10 Stocks Making Huge Moves this Week: Fastly, Sasol, Hims and More
Month-to-date, Fastly Inc.
Hims & Hers (HIMS) Sees Analyst Optimism Following Novo Resolution
Investment bank Barclays discussed Hims & Hers Health, Inc. (NYSE:HIMS)’s shares on March 11th. It raised the share price target to $29 from $25 and kept an Overweight rating on the stock.